154 related articles for article (PubMed ID: 9058723)
1. p53 abnormalities in B-cell prolymphocytic leukemia.
Lens D; De Schouwer PJ; Hamoudi RA; Abdul-Rauf M; Farahat N; Matutes E; Crook T; Dyer MJ; Catovsky D
Blood; 1997 Mar; 89(6):2015-23. PubMed ID: 9058723
[TBL] [Abstract][Full Text] [Related]
2. 5' region and exon 7 mutations of the TP53 gene in two cases of B-cell prolymphocytic leukemia.
De Angeli C; Cuneo A; Aguiari G; Roberti MG; Piva N; Moretti S; Cavazzini P; Castoldi G; del Senno L
Cancer Genet Cytogenet; 1998 Dec; 107(2):137-43. PubMed ID: 9844609
[TBL] [Abstract][Full Text] [Related]
3. p53 abnormalities in CLL are associated with excess of prolymphocytes and poor prognosis.
Lens D; Dyer MJ; Garcia-Marco JM; De Schouwer PJ; Hamoudi RA; Jones D; Farahat N; Matutes E; Catovsky D
Br J Haematol; 1997 Dec; 99(4):848-57. PubMed ID: 9432033
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of the ATM gene in T-cell prolymphocytic leukemias.
Stoppa-Lyonnet D; Soulier J; Laugé A; Dastot H; Garand R; Sigaux F; Stern MH
Blood; 1998 May; 91(10):3920-6. PubMed ID: 9573030
[TBL] [Abstract][Full Text] [Related]
5. p53 allele deletion and protein accumulation occurs in the absence of p53 gene mutation in T-prolymphocytic leukaemia and Sezary syndrome.
Brito-Babapulle V; Hamoudi R; Matutes E; Watson S; Kaczmarek P; Maljaie H; Catovsky D
Br J Haematol; 2000 Jul; 110(1):180-7. PubMed ID: 10930996
[TBL] [Abstract][Full Text] [Related]
6. B cell prolymphocytic leukaemia (B-PLL) with complex karyotype and concurrent abnormalities of the p53 and c-MYC gene.
Lens D; Coignet LJ; Brito-Babapulle V; Lima CS; Matutes E; Dyer MJ; Catovsky D
Leukemia; 1999 Jun; 13(6):873-6. PubMed ID: 10360375
[TBL] [Abstract][Full Text] [Related]
7. Incidence of the BRAF V600E mutation in chronic lymphocytic leukaemia and prolymphocytic leukaemia.
Langabeer SE; Quinn F; O'Brien D; McElligott AM; Kelly J; Browne PV; Vandenberghe E
Leuk Res; 2012 Apr; 36(4):483-4. PubMed ID: 22230299
[TBL] [Abstract][Full Text] [Related]
8. p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias.
Döhner H; Fischer K; Bentz M; Hansen K; Benner A; Cabot G; Diehl D; Schlenk R; Coy J; Stilgenbauer S; Volkmann M; Galle PR; Poustka A; Hunstein W; Lichter P
Blood; 1995 Mar; 85(6):1580-9. PubMed ID: 7888675
[TBL] [Abstract][Full Text] [Related]
9. Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance.
Cuneo A; Bigoni R; Rigolin GM; Roberti MG; Bardi A; Cavazzini F; Milani R; Minotto C; Tieghi A; Della Porta M; Agostini P; Tammiso E; Negrini M; Castoldi G
Haematologica; 2002 Jan; 87(1):44-51. PubMed ID: 11801464
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of Novel
Kanagal-Shamanna R; Bao H; Kearney H; Smoley S; Tang Z; Luthra R; Yang H; Zhang S; Lin P; Wu D; Medeiros LJ; Lu X
Leuk Lymphoma; 2022 Apr; 63(4):865-875. PubMed ID: 34898335
[No Abstract] [Full Text] [Related]
11. Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis.
Lepelley P; Preudhomme C; Vanrumbeke M; Quesnel B; Cosson A; Fenaux P
Leukemia; 1994 Aug; 8(8):1342-9. PubMed ID: 8057671
[TBL] [Abstract][Full Text] [Related]
12. ATM mutations in sporadic lymphoid tumours.
Stankovic T; Stewart GS; Byrd P; Fegan C; Moss PA; Taylor AM
Leuk Lymphoma; 2002 Aug; 43(8):1563-71. PubMed ID: 12400598
[TBL] [Abstract][Full Text] [Related]
13. Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia.
Vorechovský I; Luo L; Dyer MJ; Catovsky D; Amlot PL; Yaxley JC; Foroni L; Hammarström L; Webster AD; Yuille MA
Nat Genet; 1997 Sep; 17(1):96-9. PubMed ID: 9288106
[TBL] [Abstract][Full Text] [Related]
14. Ataxia-telangiectasia and T-cell leukemias: no evidence for somatic ATM mutation in sporadic T-ALL or for hypermethylation of the ATM-NPAT/E14 bidirectional promoter in T-PLL.
Luo L; Lu FM; Hart S; Foroni L; Rabbani H; Hammarström L; Yuille MR; Catovsky D; Webster AD; Vorechovský I
Cancer Res; 1998 Jun; 58(11):2293-7. PubMed ID: 9622061
[TBL] [Abstract][Full Text] [Related]
15. IgVH genes mutation and usage, ZAP-70 and CD38 expression provide new insights on B-cell prolymphocytic leukemia (B-PLL).
Del Giudice I; Davis Z; Matutes E; Osuji N; Parry-Jones N; Morilla A; Brito-Babapulle V; Oscier D; Catovsky D
Leukemia; 2006 Jul; 20(7):1231-7. PubMed ID: 16642047
[TBL] [Abstract][Full Text] [Related]
16. Bcl10 in chronic lymphocytic leukaemia and T-cell prolymphocytic leukaemia.
Yuille MR; Stone JG; Bradshaw PS; Houlston RS
Br J Haematol; 1999 Nov; 107(2):384-5. PubMed ID: 10583229
[TBL] [Abstract][Full Text] [Related]
17. BCL-1 rearrangements and p53 mutations in atypical chronic lymphocytic leukemia with t(11;14)(q13;q32).
De Angeli C; Gandini D; Cuneo A; Moretti S; Bigoni R; Roberti MG; Bardi A; Castoldi GL; del Senno L
Haematologica; 2000 Sep; 85(9):913-21. PubMed ID: 10980628
[TBL] [Abstract][Full Text] [Related]
18. Chronic lymphocytic leukemia and prolymphocytic leukemia with MYC translocations: a subgroup with an aggressive disease course.
Put N; Van Roosbroeck K; Konings P; Meeus P; Brusselmans C; Rack K; Gervais C; Nguyen-Khac F; Chapiro E; Radford-Weiss I; Struski S; Dastugue N; Gachard N; Lefebvre C; Barin C; Eclache V; Fert-Ferrer S; Laibe S; Mozziconacci MJ; Quilichini B; Poirel HA; Wlodarska I; Hagemeijer A; Moreau Y; Vandenberghe P; Michaux L;
Ann Hematol; 2012 Jun; 91(6):863-73. PubMed ID: 22205151
[TBL] [Abstract][Full Text] [Related]
19. Alterations of multiple tumor suppressor genes (p53 (17p13), p16INK4 (9p21), and DBM (13q14)) in B-cell chronic lymphocytic leukemia.
Newcomb EW; Rao LS; Giknavorian SS; Lee SY
Mol Carcinog; 1995 Nov; 14(3):141-6. PubMed ID: 7576105
[TBL] [Abstract][Full Text] [Related]
20. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
